Vandana Sriram serves as the Chief Financial Officer and Treasurer at Quanterix Corp, a leading company in the field of ultrasensitive biomarker detection. With an extensive background in finance and strategic planning, Vandana has been instrumental in guiding Quanterix through significant growth and development phases. She joined Quanterix in 2019, bringing with her over two decades of experience in financial management within the life sciences and healthcare industries. Prior to her role at Quanterix, Vandana held several key positions at renowned organizations. She was the Vice President of Finance at PerkinElmer, where she managed financial operations and played a crucial role in driving the company's financial strategy. Her career also includes significant stints at companies like Thermo Fisher Scientific and Hologic, where she honed her skills in financial planning, analysis, and corporate development. Vandana's strategic foresight and financial acumen have been pivotal in her ability to lead Quanterix's financial operations effectively. In her current role at Quanterix, Vandana oversees all aspects of the company's financial strategy, including budgeting, forecasting, and investor relations. Her leadership has been crucial in navigating the company through the complexities of the biotech industry, ensuring sustainable growth and financial stability. Under her guidance, Quanterix has successfully expanded its market presence and strengthened its position as a leader in the development of advanced diagnostic tools. Vandana's commitment to excellence and her ability to drive financial performance make her an invaluable asset to Quanterix and its mission to revolutionize healthcare through innovative biomarker detection technologies.